DJ Angion Biomedica IPO Priced at High End of Expectations >ANGN
By Colin Kellaher
Angion Biomedica Corp. Friday said its initial public offering of 5 million shares was priced at $16 apiece, at the top of the expected range of $14 to $16.
The Uniondale, N.Y., late-stage biopharmaceutical company said it expects gross proceeds of $80 million, adding that it granted the underwriters a 30-day option to buy up to an additional 750,000 shares.
Angion shares are due to begin trading Friday under the symbol ANGN.
Write to Colin Kellaher at firstname.lastname@example.org
(END) Dow Jones Newswires
February 05, 2021 08:41 ET (13:41 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.